Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Ltd Company History
Bafna Pharmaceuticals is engaged in the business of Manufacturing of finished pharmaceutical formulations.
1981
Started as a Proprietorship concern
1981
1984
Set up its first manufacturing unit on 04.10.1984 at Madhavaram with tablet line of installed capacity of 420 Lacs p.a.
1984
1987
Added Capsules Line with installed capacity of 300 lacs p.a.
1987
1990
Added Liquid Line with installed capacity of 45,000 ltr. p.a.
Made its first supplies to Government of Tamilnadu
1990
1994
Started Contract Manufacturing activity for Crossland Laboratories
WHO GMP Certification for Madhavarm Unit receives Submitted Dossier for registration for 57 products in Srilanka Made its first export to Srilanka
1994
1995
Started Supply to ESI corporation.
1995
2003
Received Export House" Status by Ministry of Commerce & Industry
2003
2005
Best Supplier" Award by State Pharmaceuticals Corporation of Sri Lanka
Started Construction of new plant at Grantlyon village Madhavaram Plant approved as per revised Schedule ÂMÂ
2005
2006
Registered 4 products in Ukraine.
New plant at Grantlyon Inaugurated by Governor of Tamil Nadu, on 02.10.2006.
Received ISO 9001: 2000 certificate
2006
2007
Inspection by Ghana Inspectors in 2007 got accreditation.
Rated as "SE2A" by Dun & Bradstreet
Manufacturing Licence Received for Grantlyon Unit
WHO GMP Certification for Grantlyon Unit
2007
2008
Bafna Pharmaceuticals is entering the capital market with its IPO
Bafna Pharmaceuticals have received MHRA approval from UK for the Companys new plant at Grantlayon, Chennai.
2008
2009
ISO 9001: 2000 Certificate of Registration for Manufacture and Export of Pharmaceutical products
MHRA Certificate of GMP Compliances of Manufacturer from Medicines and Healthcare products Regulatory Agency, U.K.
2009
2010
Bafna Pharmaceuticals have been awarded the Gold Quality Excellence Award 2009
Bafna Pharmaceuticals have inaugurated its Formulation Research & Development unit (Formulation Facility) in Chennai
2010
2011
Bafna Pharmaceuticals has received Indian Drug Manufacturer's Association (IDMA) Quality Excellence Award 2010 - Silver Award under the category of Formulations Units
Bafna Pharmaceuticals has received Udyog Rattan Award and Excellence Award from the Institute of Economic Studies Delhi.
Bafna Pharmaceuticals has signed an agreement with NR Jet, an affiliate of Johnson & Johnson Limited, for acquisition of the TradeMark "RARICAP".
2011
2013
Bafna Pharmaceutical Launch of RARICAP injection in domestic market
Bafna Pharmaceuticals receives product approval for Ghana
Bafna Pharmaceuticals Ltd has recommended a final dividend of Rs. 0.60 per
equity share (6%)
Bafna Pharmaceutical Launch of new products Afenac, Nocaf, Izabof in domestic market
2013
2014
Bafna Pharmaceuticals has appointed RS Gowdhaman as Company Secretary & Compliance Officer with effect from October 15, 2014.
2014
